Category: BioTech

Laboratory

£100m financing for Cambridge MedTech

MedTech Apollo Therapeutics has raised more than £100 million in financing.   The portfolio-ba...

Gelmetix

Funding boost for BioTech back pain start-up

MedTech start-up Gelmetix, the developer of a polymer treatment for chronic lower back pain, has cl...

COVID-19 virus

BioTech behind COVID drug appoints chairman ahead of IPO

ILC Therapeutics has strengthened its board and management and revealed a pre-IPO funding round ...

Ali Mortazavi

e-therapeutics raises £22.5m in share placing

Listed biotechnology firm e-therapeutics has raised £22.5 million in a conditional share placi...

Mogrify

Cell therapy transformation firm Mogrify’s Series A reaches £24m

Biopharmaceutical company Mogrify has taken its Series A financing to £24 million after raising ...

Dr Gordon Sanghera, Oxford Nanopore

Oxford Nanopore raises £195m

Oxford Nanopore Technologies has raised £195 million.  The firm, spun out of Professor Hagan B...

Exscientia

AI drug discovery company raises £378m Series D

SoftBank has backed an Oxford-based AI drug discovery company in a Series D funding round wor...

Healx

Ex-Dyson lead joins BioTech targeting rare diseases

Cambridge BioTech Healx has appointed a former key figure at Dyson as VP of artificial intelligenc...

COVID-19 virus

‘Plastic antibodies’ may improve accuracy of rapid COVID-19 tests

A BioTech company which produces synthetic antibodies has launched a new product that could improv...

Nasal spray

BioTech’s nasal spray ‘could stop COVID-19 in its tracks’

A team of scientists from the University of Bristol have announced the formation of a new BioTech ...

Insights

View All